129 related articles for article (PubMed ID: 1425800)
1. Serum levels of carboxyterminal propeptide of type I procollagen in healthy children from 1st year of life to adulthood and in metabolic bone diseases.
Saggese G; Bertelloni S; Baroncelli GI; Di Nero G
Eur J Pediatr; 1992 Oct; 151(10):764-8. PubMed ID: 1425800
[TBL] [Abstract][Full Text] [Related]
2. Serum Procollagen Type I N-Terminal Propeptide and Osteocalcin Levels in Korean Children and Adolescents.
Choi JS; Park I; Lee SJ; Ju HJ; Lee H; Kim J
Yonsei Med J; 2019 Dec; 60(12):1174-1180. PubMed ID: 31769248
[TBL] [Abstract][Full Text] [Related]
3. Effects of two years of growth hormone (GH) replacement therapy on bone metabolism and mineral density in childhood and adulthood onset GH deficient patients.
Longobardi S; Di Rella F; Pivonello R; Di Somma C; Klain M; Maurelli L; Scarpa R; Colao A; Merola B; Lombardi G
J Endocrinol Invest; 1999 May; 22(5):333-9. PubMed ID: 10401706
[TBL] [Abstract][Full Text] [Related]
4. Reference values of osteocalcin and procollagen type I N-propeptide plasma levels in a healthy Central European population aged 0-18 years.
Bayer M
Osteoporos Int; 2014 Feb; 25(2):729-36. PubMed ID: 23974858
[TBL] [Abstract][Full Text] [Related]
5. A cross-sectional study on biochemical parameters of bone turnover and vitamin d metabolites in healthy dutch children and young adults.
van der Sluis IM; Hop WC; van Leeuwen JP; Pols HA; de Muinck Keizer-Schrama SM
Horm Res; 2002; 57(5-6):170-9. PubMed ID: 12053089
[TBL] [Abstract][Full Text] [Related]
6. Insulin-like growth factor-I raises serum procollagen levels in children and adults with Laron syndrome.
Klinger B; Jensen LT; Silbergeld A; Laron Z
Clin Endocrinol (Oxf); 1996 Oct; 45(4):423-9. PubMed ID: 8959080
[TBL] [Abstract][Full Text] [Related]
7. Sex- and age-specific reference curves for serum markers of bone turnover in healthy children from 2 months to 18 years.
Rauchenzauner M; Schmid A; Heinz-Erian P; Kapelari K; Falkensammer G; Griesmacher A; Finkenstedt G; Högler W
J Clin Endocrinol Metab; 2007 Feb; 92(2):443-9. PubMed ID: 17105843
[TBL] [Abstract][Full Text] [Related]
8. The carboxyterminal propeptide of procollagen type I (PICP) in serum and biological fluids.
Risteli L
Scand J Clin Lab Invest Suppl; 1990; 202():143-6. PubMed ID: 2075430
[No Abstract] [Full Text] [Related]
9. Type I collagen and procollagen fragments in patients with metabolic bone diseases.
Lin JS; Kao JT; Tsai KS
J Formos Med Assoc; 1996 Jul; 95(7):523-9. PubMed ID: 8840753
[TBL] [Abstract][Full Text] [Related]
10. Use of a marker of collagen formation in osteoporosis studies.
Risteli J; Melkko J; Niemi S; Risteli L
Calcif Tissue Int; 1991; 49 Suppl():S24-5. PubMed ID: 1933592
[TBL] [Abstract][Full Text] [Related]
11. Evolution of circulating C-terminal propeptide of type I procollagen in patients with chronic renal failure pre and post renal transplantation.
Bonnin MR; Gonzalez MT; Griñó JM; Cruzado JM; Martínez JM; Navarro MA
Eur J Clin Chem Clin Biochem; 1996 Nov; 34(11):897-900. PubMed ID: 8960463
[TBL] [Abstract][Full Text] [Related]
12. [Measurement of serum concentration with radioimmunoassay for carboxyterminal propeptide of type 1 procollagen].
Yamamoto I; Takada M; Ohnaka Y; Yuu I; Yamamoto Y; Hamazu H; Morita R
Kaku Igaku; 1993 May; 30(5):563-9. PubMed ID: 8336416
[TBL] [Abstract][Full Text] [Related]
13. Bone mineral density and bone turnover before and after surgical cure of Cushing's syndrome.
Hermus AR; Smals AG; Swinkels LM; Huysmans DA; Pieters GF; Sweep CF; Corstens FH; Kloppenborg PW
J Clin Endocrinol Metab; 1995 Oct; 80(10):2859-65. PubMed ID: 7559865
[TBL] [Abstract][Full Text] [Related]
14. Effects of 12 months rec-GH therapy on bone and collagen turnover and bone mineral density in GH deficient children with thalassaemia major.
Sartorio A; Conte G; Conti A; Masala A; Alagna S; Rovasio P; Faglia G
J Endocrinol Invest; 2000 Jun; 23(6):356-61. PubMed ID: 10908162
[TBL] [Abstract][Full Text] [Related]
15. Serum concentrations of carboxyl-terminal propeptide of type I procollagen, amino-terminal propeptide of type III procollagen, cross-linked carboxyl-terminal telopeptide of type I collagen, and their interrelationships in schoolchildren.
Crofton PM; Wade JC; Taylor MR; Holland CV
Clin Chem; 1997 Sep; 43(9):1577-81. PubMed ID: 9299936
[TBL] [Abstract][Full Text] [Related]
16. [Age-related changes in the level of serum bone markers in healthy children].
Ivashkina TM; Kotova TN; Omarova PSh; Khlekhlina IuV; Berestovskaia VS; Ponkratova TS
Klin Lab Diagn; 2010 Nov; (11):7-10. PubMed ID: 21313747
[TBL] [Abstract][Full Text] [Related]
17. Growth hormone treatment in osteogenesis imperfecta with quantitative defect of type I collagen synthesis.
Antoniazzi F; Bertoldo F; Mottes M; Valli M; Sirpresi S; Zamboni G; Valentini R; Tató L
J Pediatr; 1996 Sep; 129(3):432-9. PubMed ID: 8804334
[TBL] [Abstract][Full Text] [Related]
18. [Serum levels of carboxyterminal propeptide of type I procollagen (PICP), cross-linked carboxyterminal telopeptide region of type I collagen (ICTP) and carboxyterminal parathyroid hormone-related protein (C-PTHrP) in hematological malignancies with bone lesions and hypercalcemia].
Tanaka K; Shiraishi K; Sakamoto A; Jojima H; Masuchi K; Okubo Y; Tanaka M; Fuzimatsu Y; Fukahori S; Osabe S; Imamura Y; Honda J; Oizumi K
Rinsho Ketsueki; 1998 Apr; 39(4):273-80. PubMed ID: 9597894
[TBL] [Abstract][Full Text] [Related]
19. Twenty-four-hour osteocalcin, carboxyterminal propeptide of type I procollagen, and aminoterminal propeptide of type III procollagen rhythms in normal and growth-retarded children.
Saggese G; Baroncelli GI; Bertelloni S; Cinquanta L; DiNero G
Pediatr Res; 1994 Apr; 35(4 Pt 1):409-15. PubMed ID: 8047377
[TBL] [Abstract][Full Text] [Related]
20. Biochemical markers of bone turnover in girls during puberty.
Blumsohn A; Hannon RA; Wrate R; Barton J; al-Dehaimi AW; Colwell A; Eastell R
Clin Endocrinol (Oxf); 1994 May; 40(5):663-70. PubMed ID: 7516828
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
